UniChem, the UK-based pharmaceuticals group, has announced an 8% rise inpre-tax profits to L26.9 million ($42.6 million) for the six months ended June 30, 1997. Sales rose 16% to L832.9 million, bolstered by the consolidation of the group's joint wholesaling venture in Portugal.
Encouraged by its results, UniChem claims that its sales are growing faster than at German rival Gehe, which won the L684 million bid battle for Lloyds Chemists (Marketletters passim).
Unichem's wholesale business sales rose 8% in the six months to June, while Gehe's UK sales for the same period only rose 3%. As well as wresting the contract away from the German group to supply Superdrug's 120 pharmacies, the group's 6.6% retail gain outstripped the 3% rise at Gehe.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze